Consequences of Oedema on the Prognosis of InTraCerebral Haemorrhage
Status: Recruiting
Location: See location...
Intervention Type: Biological, Radiation
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY
In 2020, IntraCerebral Haemorraghe (ICH) remains the most devastating type of stroke. Besides stroke unit care, no specific treatment has been proven effective yet. Perihaematomal oedema (PHO) could be a promising therapeutic target. However, the mechanisms, the natural history as well as the clinical impact of this PHO remain unclear. The COPITCH study has been designed to answer these questions
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• With a spontaneous ICH, i.e. non traumatic
• Admitted within 12 hours of stroke onset. For wake-up strokes, time of last seen well will be considered as stroke onset
• Patient insured under the French social security
• Consent form signed
Locations
Other Locations
France
CHU de Lille
RECRUITING
Lille
Contact Information
Primary
Charlotte Cordonnier, MD,PhD
charlotte.cordonnier@chu-lille.fr
0320445962
Time Frame
Start Date: 2021-06-04
Estimated Completion Date: 2025-06
Participants
Target number of participants: 500
Treatments
Experimental: Patient with intracerebral haemorrhage
Patients will be screened at admission in the stroke units right after brain MRI demonstrating the presence of blood in the brain parenchyma.
Related Therapeutic Areas
Sponsors
Collaborators: Conseil Régional Hauts-de-France, France, Fondation pour la recherche sur les AVC
Leads: University Hospital, Lille